+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Intelligence in Pathology Market by Product Type, Application, End User, Deployment Mode - Global Forecast to 2030- Product Image
Artificial Intelligence in Pathology Market by Product Type, Application, End User, Deployment Mode - Global Forecast to 2030- Product Image
Sale

Artificial Intelligence in Pathology Market by Product Type, Application, End User, Deployment Mode - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5893794
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Artificial Intelligence in Pathology Market grew from USD 101.58 million in 2024 to USD 116.52 million in 2025. It is expected to continue growing at a CAGR of 14.86%, reaching USD 233.37 million by 2030.

Unveiling the Role of AI in Transforming Pathology Practice

Artificial intelligence is ushering in a new era of diagnostic precision and operational efficiency within pathology. This introduction sets the stage by outlining the transformative potential of machine learning algorithms, digital imaging, and predictive analytics as they converge to redefine the way tissue analysis, disease classification, and clinical decision support are conducted. The integration of AI tools is not merely a technological upgrade; it represents a paradigm shift that accelerates diagnostic workflows, enhances accuracy, and enables more personalized patient care.

Stakeholders across research institutes, diagnostic laboratories, and healthcare systems are increasingly embracing AI-driven solutions to address longstanding challenges such as inter-observer variability and labor-intensive procedures. As algorithms trained on vast datasets begin to outperform conventional methods in consistency and speed, the promise of real-time insights and early disease detection becomes tangible. This opening perspective underscores why the pathology community is poised for transformative growth when AI capabilities are harnessed at scale.

Emerging Forces Reshaping the Pathology Landscape

The pathology landscape is being reshaped by factors that extend beyond incremental improvements, as breakthroughs in deep learning architectures and high-resolution imaging establish a new benchmark for diagnostic accuracy. Computational pathology platforms are no longer confined to academic prototypes but are entering mainstream clinical adoption, driven by vendors who optimize validation workflows and regulatory compliance. At the same time, whole slide imaging systems are delivering seamless integration with laboratory information systems, enabling pathologists to collaborate globally and accelerate case turnaround.

Predictive analytics is emerging as a critical component, empowering practitioners to forecast disease progression and tailor treatment regimens with unprecedented granularity. Simultaneously, workflow optimization tools are streamlining case triage and resource allocation, reducing bottlenecks and freeing experts to focus on complex interpretations. As a result, the market is witnessing a convergence of smart diagnostics and operational intelligence, propelling a landscape defined by rapid innovation cycles and heightened competitive differentiation.

Assessing the Effects of US Tariffs on AI-Driven Pathology

The introduction of new United States tariffs in 2025 has added a complex layer of consideration for suppliers and end users of AI-enabled pathology solutions. Hardware components sourced from global manufacturers, including high-throughput scanners and specialized imaging devices, are now subject to cost adjustments that ripple through procurement budgets. Software licensing agreements, particularly for advanced data analysis and workflow management platforms, face renewed scrutiny as pricing structures adapt to revised import duties.

This evolving tariff environment compels vendors to reassess supply chains and explore alternative manufacturing hubs or localization strategies. At the same time, healthcare providers must weigh the total cost of ownership against the operational benefits of AI integration. Forward-looking organizations are negotiating long-term partnerships to stabilize pricing while investing in cloud deployment models that mitigate upfront capital expenditures. The net result is a market in which tariff-driven dynamics influence strategic sourcing decisions alongside clinical considerations.

Dissecting Market Layers Through Product, Application, End User, and Deployment Lenses

In examining the market through the lens of product type, it is essential to understand the interplay between services and solutions. Professional services and training and support offerings are being tailored to ensure seamless adoption of AI platforms, while hardware systems and software suites-ranging from robust data analysis applications to advanced whole slide imaging systems and workflow management tools-constitute the technological backbone of digital pathology environments.

Shifting to application, computational pathology has emerged as a cornerstone, complemented by digital pathology workflows that leverage telepathology and whole slide imaging to facilitate remote case review. Predictive analytics solutions, featuring prognostic models and risk prediction algorithms, are gaining traction among clinicians seeking preemptive insights. Workflow optimization continues to refine case triage processes and resource allocation protocols, ensuring that diagnostic throughput aligns with clinical demand.

The end-user dimension reveals diverse adoption patterns. Diagnostic laboratories, encompassing both hospital-based and reference labs, are integrating AI to elevate throughput and accuracy. Hospitals and clinics, whether large academic medical centers or smaller community institutions, are implementing solutions to streamline pathology services. Pharmaceutical and biotech organizations, from agile startups to established large pharma, are leveraging AI for biomarker discovery and trial stratification, while academic research centers and private laboratories drive innovation through translational studies.

Deployment mode further differentiates market offerings, as cloud-based platforms-available in both private and public cloud configurations-compete with on-premise installations. Cloud environments facilitate scalability and reduce infrastructure overhead, whereas on-premise solutions appeal to institutions prioritizing data sovereignty and integration with legacy systems. These combined segmentation perspectives provide a granular understanding of market drivers, user requirements, and adoption barriers across the AI in pathology ecosystem.

Regional Dynamics Driving AI Adoption Across Global Markets

When observing the geographical trends, the Americas region stands at the forefront, propelled by substantial investments in digital pathology infrastructure and a robust regulatory framework that encourages AI adoption. North American healthcare providers are rapidly upgrading laboratory workflows, supported by government initiatives and private funding for precision medicine initiatives.

Across Europe, the Middle East, and Africa, diverse healthcare landscapes yield varying levels of AI integration. Western European nations lead with standardized reimbursement pathways and established clinical validation studies, while Middle Eastern markets are investing in state-of-the-art diagnostic centers. In Africa, pilot programs are demonstrating the potential of AI to expand diagnostic reach in underserved regions, often through partnerships with global technology providers.

The Asia-Pacific region exhibits dynamic growth fueled by both mature markets such as Japan and Australia, and emerging economies including China and India. Large hospital networks are deploying AI-driven pathology platforms to address high-volume case loads, while government-funded research initiatives accelerate the development of localized algorithms. These regional distinctions underline the necessity for tailored go-to-market strategies and reinforce the global momentum of AI in pathology innovation.

Competitive Landscape Highlights from Leading Industry Players

The competitive landscape is marked by established incumbents and agile upstarts positioning their AI pathology portfolios through differentiated features and service models. Key players are investing in partnerships with leading research institutions to validate algorithm performance, securing regulatory clearances, and enhancing interoperability with laboratory information systems. Strategic acquisitions are consolidating capabilities, with software companies integrating hardware offerings to deliver end-to-end digital pathology ecosystems.

In parallel, niche vendors are focusing on specialized applications such as prognostic analytics or case triage, leveraging domain expertise to carve out dedicated market segments. Alliances between diagnostic laboratories and technology firms are creating co-developed solutions that prioritize clinical validation and streamlined implementation. This multifaceted competitive environment underscores the importance of innovation velocity, evidence-based performance, and customer-centric service delivery.

Strategic Imperatives for Leaders to Navigate the AI Pathology Frontier

Industry leaders should prioritize establishing comprehensive validation studies that demonstrate the clinical efficacy of AI pathology solutions. By collaborating with academic and clinical research centers, organizations can generate robust evidence to support regulatory submissions and payer engagements. Furthermore, executives must consider hybrid deployment strategies, combining cloud and on-premise environments to align with data governance requirements and budgetary constraints.

Investment in comprehensive training and support services is critical to drive user adoption and minimize implementation friction. Customized educational programs for pathologists and laboratory staff will bridge skill gaps and promote confidence in AI-assisted workflows. It is equally important to cultivate strategic partnerships across the technology ecosystem, from hardware manufacturers to software integrators, to deliver cohesive solutions that address end-to-end pathology needs.

Finally, adopting an agile development roadmap will enable continuous refinement of algorithms based on real-world feedback. Organizations that maintain close communication channels with end users can prioritize feature updates that directly address operational challenges. This adaptive approach will not only enhance clinical outcomes but also secure sustained competitive advantage in a rapidly evolving market.

Robust Framework Underpinning Our Comprehensive Research

The research methodology employed a multi-stage approach to ensure comprehensiveness and rigor. Primary interviews were conducted with pathologists, laboratory managers, and technology executives to capture firsthand perspectives on adoption drivers, pain points, and unmet clinical needs. Secondary research incorporated peer-reviewed publications, regulatory documents, and industry reports to validate market dynamics and technology trends.

Quantitative analysis involved mapping key vendors across product offerings, application use cases, and deployment modalities. Segmentation frameworks were developed based on product type, application, end user, and deployment mode to illuminate distinct market pockets. Geographic assessments were based on regional healthcare spending patterns, regulatory environments, and funding initiatives for digital health.

Data triangulation was achieved by cross-referencing findings from stakeholder interviews with real-world performance metrics and case studies. This rigorous methodology ensures that the insights presented are grounded in empirical evidence, reflecting the current state of AI in pathology and the factors shaping its future trajectory.

Synthesizing Insights to Illuminate the Future of AI in Pathology

The convergence of artificial intelligence and pathology heralds a transformative era in diagnostic medicine. As the industry grapples with regulatory complexities, tariff influences, and varied adoption rates across sectors and regions, the underlying trajectory remains consistently upward. Segmentation analysis reveals niche areas of growth in predictive analytics and digital pathology, while regional insights highlight the interplay between healthcare infrastructure and AI readiness.

Key takeaways underscore the importance of cross-disciplinary collaboration, agile development cycles, and customer-centric service models to achieve sustainable innovation. Companies that demonstrate clinical validation, maintain strategic partnerships, and deliver flexible deployment options will be best positioned to capture emerging opportunities. The cumulative insights presented in this executive summary lay a solid foundation for stakeholders to navigate the AI pathology landscape with clarity and confidence.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Services
      • Professional Services
      • Training & Support
    • Solutions
      • Hardware
      • Software
        • Data Analysis Software
        • Whole Slide Imaging System
        • Workflow Management Software
  • Application
    • Computational Pathology
    • Digital Pathology
      • Telepathology
      • Whole Slide Imaging
    • Predictive Analytics
      • Prognostic Models
      • Risk Prediction
    • Workflow Optimization
      • Case Triage
      • Resource Allocation
  • End User
    • Diagnostic Laboratories
      • Hospital-Based Labs
      • Reference Laboratories
    • Hospitals & Clinics
      • Large Hospitals
      • Small & Mid-Size Hospitals
    • Pharma & Biotech
      • Biotech Startups
      • Large Pharma
    • Research Institutes
      • Academic Research Centers
      • Private Labs
  • Deployment Mode
    • Cloud
      • Private Cloud
      • Public Cloud
    • On-Premise
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Koninklijke Philips N.V.
  • Roche Diagnostics International AG
  • Siemens Healthineers AG
  • Fujifilm Holdings Corporation
  • Danaher Corporation
  • PathAI, Inc.
  • Paige, Inc.
  • Proscia, Inc.
  • Indica Labs, Inc.
  • Inspirata, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Artificial Intelligence in Pathology Market, by Product Type
8.1. Introduction
8.2. Services
8.2.1. Professional Services
8.2.2. Training & Support
8.3. Solutions
8.3.1. Hardware
8.3.2. Software
8.3.2.1. Data Analysis Software
8.3.2.2. Whole Slide Imaging System
8.3.2.3. Workflow Management Software
9. Artificial Intelligence in Pathology Market, by Application
9.1. Introduction
9.2. Computational Pathology
9.3. Digital Pathology
9.3.1. Telepathology
9.3.2. Whole Slide Imaging
9.4. Predictive Analytics
9.4.1. Prognostic Models
9.4.2. Risk Prediction
9.5. Workflow Optimization
9.5.1. Case Triage
9.5.2. Resource Allocation
10. Artificial Intelligence in Pathology Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.2.1. Hospital-Based Labs
10.2.2. Reference Laboratories
10.3. Hospitals & Clinics
10.3.1. Large Hospitals
10.3.2. Small & Mid-Size Hospitals
10.4. Pharma & Biotech
10.4.1. Biotech Startups
10.4.2. Large Pharma
10.5. Research Institutes
10.5.1. Academic Research Centers
10.5.2. Private Labs
11. Artificial Intelligence in Pathology Market, by Deployment Mode
11.1. Introduction
11.2. Cloud
11.2.1. Private Cloud
11.2.2. Public Cloud
11.3. On-Premise
12. Americas Artificial Intelligence in Pathology Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Artificial Intelligence in Pathology Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Artificial Intelligence in Pathology Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Koninklijke Philips N.V.
15.3.2. Roche Diagnostics International AG
15.3.3. Siemens Healthineers AG
15.3.4. Fujifilm Holdings Corporation
15.3.5. Danaher Corporation
15.3.6. PathAI, Inc.
15.3.7. Paige, Inc.
15.3.8. Proscia, Inc.
15.3.9. Indica Labs, Inc.
15.3.10. Inspirata, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET MULTI-CURRENCY
FIGURE 2. ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET MULTI-LANGUAGE
FIGURE 3. ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PROFESSIONAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY TRAINING & SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY WHOLE SLIDE IMAGING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY WORKFLOW MANAGEMENT SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY COMPUTATIONAL PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY TELEPATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY WHOLE SLIDE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PREDICTIVE ANALYTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PROGNOSTIC MODELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY RISK PREDICTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY WORKFLOW OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY CASE TRIAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY RESOURCE ALLOCATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY WORKFLOW OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY HOSPITAL-BASED LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY LARGE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SMALL & MID-SIZE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PHARMA & BIOTECH, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY BIOTECH STARTUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY ACADEMIC RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PRIVATE LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY CLOUD, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY WORKFLOW OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY WORKFLOW OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 88. CANADA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. CANADA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 90. CANADA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 91. CANADA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 92. CANADA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. CANADA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 94. CANADA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 95. CANADA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY WORKFLOW OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 96. CANADA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. CANADA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 98. CANADA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 99. CANADA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 100. CANADA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 101. CANADA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 102. CANADA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 103. MEXICO ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. MEXICO ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 105. MEXICO ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 106. MEXICO ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 107. MEXICO ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. MEXICO ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 109. MEXICO ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 110. MEXICO ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY WORKFLOW OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 111. MEXICO ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. MEXICO ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 113. MEXICO ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 114. MEXICO ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 115. MEXICO ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 116. MEXICO ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 117. MEXICO ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY WORKFLOW OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY WORKFLOW OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY WORKFLOW OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 166. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY WORKFLOW OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 179. GERMANY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. GERMANY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 181. GERMANY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 182. GERMANY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 183. GERMANY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. GERMANY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 185. GERMANY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 186. GERMANY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY WORKFLOW OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 187. GERMANY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. GERMANY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 189. GERMANY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 190. GERMANY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 191. GERMANY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 192. GERMANY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 193. GERMANY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 194. FRANCE ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. FRANCE ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 196. FRANCE ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 197. FRANCE ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 198. FRANCE ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. FRANCE ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 200. FRANCE ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 201. FRANCE ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY WORKFLOW OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 202. FRANCE ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. FRANCE ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 204. FRANCE ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 205. FRANCE ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 206. FRANCE ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 207. FRANCE ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 208. FRANCE ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 209. RUSSIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. RUSSIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 211. RUSSIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 212. RUSSIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 213. RUSSIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY WORKFLOW OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. RUSSIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 224. ITALY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. ITALY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 226. ITALY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 227. ITALY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 228. ITALY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. ITALY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 230. ITALY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 231. ITALY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY WORKFLOW OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 232. ITALY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. ITALY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 234. ITALY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 235. ITALY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 236. ITALY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 237. ITALY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 238. ITALY ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 239. SPAIN ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. SPAIN ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 241. SPAIN ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 242. SPAIN ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 243. SPAIN ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. SPAIN ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 245. SPAIN ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 246. SPAIN ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY WORKFLOW OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 247. SPAIN ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. SPAIN ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 249. SPAIN ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 250. SPAIN ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 251. SPAIN ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 252. SPAIN ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 253. SPAIN ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY WORKFLOW OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY WORKFLOW OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PHARMA & BIOTECH, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY CLOUD, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA ARTIFICIAL INTELLIGE

Companies Mentioned

The companies profiled in this Artificial Intelligence in Pathology market report include:
  • Koninklijke Philips N.V.
  • Roche Diagnostics International AG
  • Siemens Healthineers AG
  • Fujifilm Holdings Corporation
  • Danaher Corporation
  • PathAI, Inc.
  • Paige, Inc.
  • Proscia, Inc.
  • Indica Labs, Inc.
  • Inspirata, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages195
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 116.52 Million
Forecasted Market Value ( USD ) by 2030 $ 233.37 Million
Compound Annual Growth Rate14.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Artificial Intelligence in Oncology Market by Product Type, Technology, Deployment Mode, Cancer Type, Application, End-Use - Global Forecast to 2030 - Product Image

Artificial Intelligence in Oncology Market by Product Type, Technology, Deployment Mode, Cancer Type, Application, End-Use - Global Forecast to 2030

  • Report
  • 180 Pages
  • Global
From
Artificial Intelligence in Pathology Market Report 2025 - Product Image

Artificial Intelligence in Pathology Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Artificial Intelligence in Biomedical Market by Component, Technology, Business Function, Application, End User, Deployment Mode - Global Forecast to 2030 - Product Image

Artificial Intelligence in Biomedical Market by Component, Technology, Business Function, Application, End User, Deployment Mode - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Edge AI Software Market by Technology (Generative AI, Machine Learning (ML) (Supervised Learning, Reinforcement Learning), Natural Language Processing (NLP), Computer Vision), Data Modality (Spatial Data, Temporal Data) - Global Forecast to 2030 - Product Image

Edge AI Software Market by Technology (Generative AI, Machine Learning (ML) (Supervised Learning, Reinforcement Learning), Natural Language Processing (NLP), Computer Vision), Data Modality (Spatial Data, Temporal Data) - Global Forecast to 2030

  • Report
  • 345 Pages
  • Global
From
AI API Market by Product Type (Computer Vision API (Object Detection), Generative AI API, Speech API, Voice API (ASR, VAD), Text API (NER, Sentiment Analysis), Document Parsing API (OCR, Document Classification), Translation API) - Global Forecast to 2030 - Product Image

AI API Market by Product Type (Computer Vision API (Object Detection), Generative AI API, Speech API, Voice API (ASR, VAD), Text API (NER, Sentiment Analysis), Document Parsing API (OCR, Document Classification), Translation API) - Global Forecast to 2030

  • Report
  • 322 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.